NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
Chronicle-Tribune9h
Mississinewa holds strategic planning meeting
Hundreds of people gathered in the cafeteria at Mississinewa High School on Wednesday evening to hear the corporation’s 2025 Strategic Planning presentation.
Chronicle-Tribune10h
'We want your input'
Hundreds of people gathered in the cafeteria at Mississinewa High School on Wednesday evening to hear the corporation’s 2025 ...
Harvard Business Review10h
The Strategic Genius of Taylor Swift
At age 35, Taylor Swift has been at the top of the music industry for two decades. She’s one of the top 10 best-selling ...
Fortis targets $26B capital plan with 6.5% annual rate base growth through 2029
Fortis Inc. delivers strong Q4 2024 results with 6% EPS growth, a $26B capital plan, and major opportunities in Arizona.